How does a company like Gilead get away with charging Americans all told
over $100,000 for its hepatitis C treatment and through an agreement
with a generic drug company (I presume a limited license agreement) make it possible
for Vietnamese to get the same thing for around $6,000?
That the States permits this kind of obvious gouging indicates there is
something seriously wrong with its patent and copyright monopoly
approach. A tenth the profit they are taking would still be enough to
motivate the risk taking and study expenses.
No comments:
Post a Comment